Literature DB >> 23711678

Venous symptoms in C0 and C1 patients: UIP consensus document.

J P Benigni1, I Bihari, E Rabe, J F Uhl, H Partsch, A Cornu-Thenard, A Jawien.   

Abstract

This UIP document provides an update on venous symptoms in CO and C1 patients. The correlation between venous symptoms and the presence of telangiectases and/or reticular veins is one of the most controversial topics in chronic venous disorders. As symptoms may be non-specific of chronic venous disease, it is important to differentiate venous symptoms from symptoms of other causes. Some data from the Bonn Vein Study suggest that the risk to develop venous symptoms is increased in women, advanced age and obesity. Treatment is based on physical advice, elastic compression, venoactive drugs, sclerotherapy, correction of foot static disorders and reduction of body weight. Future research should be promoted on venous symptoms in epidemiological and follow-up studies, about the relationship between female hormone levels and symptomatic telangiectasias, and between venous pain and foot static disorders in C0s C1s patients.

Entities:  

Mesh:

Year:  2013        PMID: 23711678

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  4 in total

1.  Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.

Authors:  Matheus Bertanha; Rodrigo Gibin Jaldin; Regina Moura; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Carlos Eduardo Pinheiro Lúcio Filho; Giovana Piteri Alcantara; Carlos Roberto Padovani; Winston Bonetti Yoshida; Marcone Lima Sobreira
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

2.  Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.

Authors:  Matheus Bertanha; Marcone Lima Sobreira; Carlos Eduardo Pinheiro Lúcio Filho; Jamil Victor de Oliveira Mariúba; Rafael Elias Farres Pimenta; Rodrigo Gibin Jaldin; Andrei Moroz; Regina Moura; Hamilton Almeida Rollo; Winston Bonetti Yoshida
Journal:  Trials       Date:  2014-12-19       Impact factor: 2.279

3.  Delphi case: Sharing of clinical experiences for improvement in the treatment of chronic venous disease.

Authors:  Giuseppe Camporese; Teresa Lucia Aloi; Angelo Santoliquido
Journal:  Front Cardiovasc Med       Date:  2022-07-18

4.  Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.

Authors:  Matheus Bertanha; Paula Angeleli Bueno de Camargo; Regina Moura; Winston Bonetti Yoshida; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Giovana Piteri Alcantara; Dênia Reis de Paula; Marcone Lima Sobreira
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.